11.04.2014
- U.S. biotechnology firm Amgen, the world's largest, is ending its agreement with the U.K. drugmaker GlaxoSmithkline for the marketing of its osteoporosis drug in some regions...
18.07.2013
- Obesity drug maker Vivus, embroiled in a bitter proxy war with its top shareholder First Manhattan, said on Wednesday that FMC had rejected an offer to give the sides equal...
26.10.2012
- Boehringer Ingelheim Pharmaceuticals agreed to pay $95 million to U.S. government agencies to settle civil allegations that it illegally marketed drugs for unapproved uses, the U.S...
10.05.2012
- A U.S. Senate panel has launched a probe of possible links between three drugmakers and nonprofit medical groups that advocated for increasing the use of prescription painkillers...
